:max_bytes(150000):strip_icc():focal(749x0:751x2)/Ali-Eastburn10-080825-8f454297feaf4b2b82c277ea969e6b58.jpg)
Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
Truth Originally for type 2 diabetes, Semaglutide and Tirzepatide effectively aid weight loss
Uncontrolled blood sugar levels can lead to serious complications if left unmanaged
4 Comparison of change from baseline by week for selected cardiometabolic endpoints for semaglutide versus placebo
Wegovy (semaglutide) is a GLP-1 receptor agonist prescribed for chronic weight management in the UK
Azathioprine and 6-mercaptopurine (6-MP) [see Warnings and Precautions (5.2)] may be continued during treatment with HUMIRA if necessary
Rate of cardiovascular death, nonfatal myocardial infarction (heart attack), or nonfatal stroke was significantly lower among patients receiving semaglutide than among those receiving placebo
US$ 22.65
US$ 28.39
US$ 22.46
US$ 26.20
US$ 29.61
US$ 29.21
